Dr. Jonsdottir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Dept Of Internal Medicine
Iowa City, IA 52242Phone+1 319-467-2000
Education & Training
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2019 - 2020
University of IcelandClass of 2010
Certifications & Licensure
IA State Medical License 2016 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboringexon 19, p.L755P mutation: case report.Gudbjorg Jonsdottir, Mark Smith, Samuel Wood, Taher Abu Hejleh, Muhammad Furqan
Translational Lung Cancer Research. 2023-04-28 - 8 citationsThe half-painted picture: Reviewing the mental health impacts of cancer screening.Lauren P Wadsworth, Inga Wessman, Andri Steinþór Björnsson, Gudbjorg Jonsdottir, Sigurður Yngvi Kristinsson
Medicine. 2022-09-23 - 9 citationsCumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.Gudbjorg Jonsdottir, Magnus Björkholm, Ingemar Turesson, Malin Hultcrantz, Benjamin Diamond
European Journal of Haematology. 2021-05-28
Press Mentions
Previous Malignancy May Increase Risk of Subsequent Malignancy in Patients with MyelomaJanuary 11th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
